FindTrial
Sign In

A Prospective study on women with infertility to evaluate role of low-dose gonadotropin and clomiphene citrate

A Prospective Study Evaluating the Role of Low-Dose Gonadotropin Plus Continuous Clomiphene Citrate Protocol in IVF Controlled Ovarian Stimulation Across Different Ovarian Responder Categories - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103220
Enrollment
100
Registered
2026-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Clomiphene citrate 100mg Gonadotropin 150 IU: Clomiphene citrate 100 mg orally daily from Day 2 till day of trigger Gonadotropins 150 IU daily from Day 2 till trigger Control Interventi

Sponsors

Dr Ekika Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women undergoing IVF/ICSI, including poor, normal and hyper-responders

Exclusion criteria

Exclusion criteria: If on Day 9, multiple follicles are less than 15 mm with LH level less than 10 IU

Design outcomes

Primary

MeasureTime frame
Number of oocytes retrieved Number of mature (MII) oocytes Clinical pregnancy rateTimepoint: Number of oocytes retrieved at Day 16 or 17 Number of mature (MII) oocytes at Day 16 or 17 Clinical pregnancy rate at end of week 6—

Secondary

MeasureTime frame
Total gonadotropin dose used Duration of stimulation Fertilization rate Embryo quality and blastocyst formation Implantation rate Cycle cancellation rate Incidence and severity of OHSS Timepoint: Week 4—

Countries

India

Contacts

Public ContactDr Ekika Singh

Sharda Narayan Hospital

ekika.singh@snhospital.org9839047666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026